作者：
Reck,M. [1]
;
Kaiser,R. [2]
;
Mellemgaard,A. [3]
;
Douillard,J.-Y. [4]
;
Orlov,S. [5]
;
Krzakowski,M. [6]
;
vonPawel,J. [7]
;
Gottfried,M. [8]
;
Bondarenko,I. [9]
;
Liao,M. [10]
;
Gann,C.-N. [11]
;
Barrueco,J. [12]
;
Gaschler-Markefski,B. [13]
;
Novello,S. [14]
作者单位：
Lung Cancer Unit, Meir Medical Centre, Kfar Saba, Israel
[1]
Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, United States
[2]
Medical Data Services and Biostatistics, Boehringer Ingelheim Pharma, Biberach an der Riss, Germany
[3]
Department of Oncology, University of Turin, AUO San Luigi, Orbassano, Italy
[4]
Department of Medical Affairs, Boehringer Ingelheim Pharma, Ingelheim, Germany
[5]
Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Grosshansdorf, Germany, German Centre
[6]
Department of Thoracic Oncology, St Petersburg State Medical University, St Petersburg, Russian
[7]
Department of Medical Oncology, Centre ICO René Gauducheau, Nantes, France
[8]
The Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland
[9]
Pneumology Clinic, Asklepios Fachkliniken Munchen-Gauting, Gauting, Germany
[10]
Department of Oncology, Herlev University Hospital, Herlev, Denmark
[11]
Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
[12]
Clinical Facility, Dnepropetrovsk Medical Academy, Dnepropetrovsk Municipal Clinical Hospital no 4
[13]
Corporate Division Medicine, TA Oncology, Boehringer Ingelheim Pharma, Biberach an der Riss, Germany
[14]
发布时间
2014-04-05
换一批
